UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Heart, lung & circulation, ISSN 1443-9506, 2016, Volume 25, Issue 9, pp. 895 - 951
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | New Zealand | Societies, Medical | Humans | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - physiopathology | Acute Coronary Syndrome - therapy | Female | Male | Thoracic Surgery | Australia | Practice Guidelines as Topic | Heart failure | Medical colleges | Care and treatment | Emergency medicine | Practice guidelines (Medicine) | Cardiology | Coronary heart disease | Epidemiology | Trade and professional associations | Cardiovascular agents | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2006, Volume 355, Issue 21, pp. 2203 - 2216
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Heparin - therapeutic use | Male | Enoxaparin - therapeutic use | Recombinant Proteins - adverse effects | Angioplasty, Balloon, Coronary | Angina, Unstable - drug therapy | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Hirudins - adverse effects | Angina, Unstable - therapy | Coronary Artery Bypass | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Aggregation | Evaluation | Blood platelets | Drug therapy | Heart attacks | Medical imaging | Mortality | Informed consent | Clinical medicine | Angina pectoris | Acute coronary syndromes | Health education | Patients | Index Medicus | Abridged Index Medicus | Bypass cardiopulmonar | Bypass cardiopulmonary | Malalties coronà ries | Anticoagulants (Medicine) | Heparin | Heparina | Anticoagulants (Medicina) | Coronary diseases
Journal Article
3.
Full Text
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
The New England journal of medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 10, pp. 1006 - 1017
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Smoking - blood | Humans | Middle Aged | Anticoagulants - therapeutic use | Heparin - therapeutic use | Male | Anticoagulants - adverse effects | Heparin - adverse effects | Enoxaparin - adverse effects | Incidence | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon, Coronary - adverse effects | Regression Analysis | Enoxaparin - administration & dosage | Myocardial Ischemia - therapy | Female | Aged | Myocardial Ischemia - mortality | Hemorrhage - chemically induced | Stents | Enoxaparin | Drug therapy | Angioplasty | Health aspects | Cardiac patients | Methods | Anticoagulants | Heart attacks | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Medical journal of Australia, ISSN 0025-729X, 08/2016, Volume 205, Issue 3, pp. 128 - 133
Cardiovascular diseases | Health services administration | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Emergency Service, Hospital | Humans | Anticoagulants - therapeutic use | Male | Cardiology - standards | Angioplasty, Balloon, Coronary | New Zealand | Acute Coronary Syndrome - rehabilitation | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Female | Disease Management | Australia | Platelet Aggregation Inhibitors - therapeutic use | Societies, Medical - standards | Practice Guidelines as Topic | Practice guidelines (Medicine) | Care and treatment | Diagnosis | Acute coronary syndrome | Analysis | Risk factors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Biological and medical sciences | Myocarditis. Cardiomyopathies | Medical sciences | Coronary heart disease | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - epidemiology | Follow-Up Studies | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Angina, Unstable - drug therapy | Ticlopidine - adverse effects | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Purinergic P2 Receptor Antagonists - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Purinergic P2 Receptor Antagonists - adverse effects | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - drug therapy | Aged | Myocardial infarction | Cerebral infarction | Aspirin | Heart attacks | Medical imaging | Angina | Angina pectoris | Patients | Bleeding | Ischemia | Patient safety | Clopidogrel | Acute coronary syndromes | Heart diseases | Age | Index Medicus | Abridged Index Medicus
Journal Article
Medical journal of Australia, ISSN 0025-729X, 02/2014, Volume 200, Issue 3, pp. 157 - 160
Cardiovascular diseases | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Length of Stay | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Rural Population - statistics & numerical data | Risk Assessment | Comorbidity | Humans | South Australia - epidemiology | Primary Health Care - organization & administration | Hospitals, Rural | Coronary Angiography | Health Services Accessibility | Cardiac Care Facilities - organization & administration | Patient Transfer | Rural Health Services | Diagnosis | Australia | Statistics | Patient outcomes | Mortality | Heart attack | Index Medicus
Journal Article